Talk:Blood plasma fractionation
 | This article is rated Start-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | |||||||||||||
| ||||||||||||||
Untitled edit
For your article it could be useful to describe the Cohn process and other processes in more detailed that relates to blood plasma fractionation in the article itself rather than linking it. Bassmaster1137 (talk) 07:20, 18 December 2008 (UTC)
merging with Blood fractionation edit
I think it's a bad idea, as the two subjects, though related, are quite distinct. One involves separating cells from a suspension, and the other involves separating components of a solution. WolfmanSF (talk) 21:53, 28 January 2009 (UTC)
Bad Idea! edit
I work in transfusion medicine, specifically Blood Banking and Plasma fractionation is an entirely different process, with entirely different outcomes and products. —Preceding unsigned comment added by Cogsmeister (talk • contribs) 10:02, 3 February 2009 (UTC)
Bad Idea- I agree! "Blood fractionation" are blood components - cells, platelets, plasma (as therapetical product)- customers are different, processes are diffrent, different professions are dealing with these two items. I work in a Blood Bank. Mio —Preceding unsigned comment added by 89.212.33.254 (talk) 09:21, 28 November 2009 (UTC)
Coagadex improved treatment for Factor X deficiency edit
Recently in 2015 in US and 2016 in Europe a purified Factor X product has been approved tradename Coagadex to replace the impure mix of proteins provided by protein complex concentrate (PCC) as a treatment for Factor X deficiency. — Preceding unsigned comment added by Chubbly69 (talk • contribs) 18:28, 15 October 2016 (UTC)